De Novo Design of Near‐Infrared Fluorescent Agents Activated by Peroxynitrite and Glutathione‐Responsive Imaging for Diabetic Liver Disease
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202302466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Renfeng Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, Universi…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Liver Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Science and Technology Project of Hunan Province, Hunan Provincial Natural Science Foundation of China, Special Funding for the Construction of Innovative Provinces in Hunan.
Abstract (Originalsprache)
Diabetes and its complications, such as diabetes liver disease, is a major problem puzzling people's health. The detection of redox states in its pathological process can effectively help us gain a deeper understanding of the disease. The pair of oxidation–reduction substances peroxynitrite (ONOO − ) and glutathione (GSH) is considered to be closely related to their occurrence and development. Thus, direct visualization of ONOO − and GSH in diabetes liver disease is critical to evaluate the disease at the molecular level. Herein, two activatable agents NTCF‐ONOO − and NTCF‐GSH are prepared for selectively detecting ONOO − and GSH through protection and deprotection strategies based on hydroxyl and amino groups of near‐infrared fluorophore. Fluorescence imaging of exogenous and endogenous ONOO − and GSH changes in living cells and in vivo is observed. The ONOO − and GSH level in the diabetes liver disease cellular model are visualized and the possible redox imbalance mechanism related to the oxidized (NAD + ) and reduced (NADH) nicotinamide adenine dinucleotides is explored in this process. Moreover, these probes can sensitively recognize ONOO − and GSH in the process of oxidative stress resulting from streptozotocin and streptozotocin/acetaminophen‐induced complex diabetic liver disease in vivo. In addition, they can be applied for monitoring the clinical serum sample related with diabetic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, 421002, China.
- Hunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, Clinical Research Institute, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 4…
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, P. R. China.
ORCID-Profile: Dan Cheng
Förderung
- Science and Technology Project of Hunan Province
- Hunan Provincial Natural Science Foundation of China
- Special Funding for the Construction of Innovative Provinces in Hunan
- China Postdoctoral Science Foundation
Zitieren
APA
Jiang, R., Zhang, H., Liu, Q., Yang, X., He, L., Yuan, L., & Cheng, D. (2024). De Novo Design of Near‐Infrared Fluorescent Agents Activated by Peroxynitrite and Glutathione‐Responsive Imaging for Diabetic Liver Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302466
Vancouver
Jiang R, Zhang H, Liu Q, Yang X, He L, Yuan L, et al. De Novo Design of Near‐Infrared Fluorescent Agents Activated by Peroxynitrite and Glutathione‐Responsive Imaging for Diabetic Liver Disease. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302466
BibTeX
@article{Jiang2024,
author = {Jiang, Renfeng and Zhang, Hongshuai and Liu, Qian and Yang, Xuefeng and He, Longwei and Yuan, Lin and Cheng, Dan},
title = {De Novo Design of Near‐Infrared Fluorescent Agents Activated by Peroxynitrite and Glutathione‐Responsive Imaging for Diabetic Liver Disease},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202302466}
}
EUVIMED